Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adaptimmune Ther ADR (NQ: ADAP )

3.630 USD +0.010 (+0.28%)
Streaming Delayed Price Updated: 9:54 AM EDT, Jul 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,897
Open 3.590
Bid (Size) 3.610 (8)
Ask (Size) 3.630 (7)
Prev. Close 3.620
Today's Range 3.560 - 3.630
52wk Range 3.550 - 10.93
Shares Outstanding 932,984,520
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
First Week of ADAP March 2022 Options Trading
Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options become available this week, for the March 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
Peek Under The Hood: IBB Has 18% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel

Performance

YTD
-39.60%
-39.60%
1 Month
-16.55%
-16.55%
3 Month
-35.52%
-35.52%
6 Month
-36.87%
-36.87%
1 Year
-60.02%
-60.02%

More News

Read More
Why Adaptimmune Therapeutics Stock Sank in the First Half of 2021
Tags ADAP GSK Market News
From Motley Fool
Oversold Conditions For Adaptimmune Therapeutics
Tags Stocks
From Market News Video
Analysts Forecast 16% Upside For MOON
Tags ETFs
From ETF Channel
Interesting ADAP Put And Call Options For July 16th
Tags Stocks
From Market News Video
2 Biotech Penny Stocks That Are Vastly Superior Investments to Dogecoin
Tags CHGCY DOGE VSTM
From Motley Fool
Thinking about buying stock in Oncternal Therapeutics, Polarityte, Adaptimmune Therapeutics, Oncolytics Biotech, or Precipio?
From PR Newswire
Why Adaptimmune Therapeutics Crushed the Market Today
Tags Market News ADAP
From Motley Fool
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Tags GBT AFIB BHVN
From Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Tags Penny Stocks ASMB ETON
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]